Related Experiment Videos

[RNA Interference targeting GRP75 decreases cisplatin resistance in human lung adenocarcinoma cell]

Sien Shi1, Zefeng He, Jianchun Cai

  • 1Department of Tumor Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China. shi_sien@hotmail.com

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|April 19, 2011
PubMed
Abstract

Insights

Overexpression of GRP75 (heat shock protein) in lung cancer cells contributes to cisplatin resistance. Downregulating GRP75 via RNAi enhances sensitivity by affecting p53 and bcl-2 expression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Heat shock proteins (HSPs), including GRP75, are implicated in cancer cell resistance.
  • GRP75, a mitochondrial membrane-bound molecular chaperone, is overexpressed in certain resistant cancer cells.
  • Understanding GRP75's role is crucial for overcoming therapeutic resistance.

Purpose of the Study:

  • To investigate the role of GRP75 in cancer cell resistance mechanisms.
  • To downregulate GRP75 expression using RNA interference (RNAi).
  • To assess the impact of GRP75 silencing on cisplatin sensitivity in lung cancer cells.

Main Methods:

  • Establishment of a cisplatin-resistant human lung adenocarcinoma cell line (A549/CDDP).
  • Transfection of GRP75-specific shRNA into A549 and A549/CDDP cells via lentivirus.
  • Western blot and MTT assays to evaluate GRP75 expression, protein levels (p53, bcl-2), and cisplatin sensitivity.

Main Results:

  • Successful downregulation of GRP75 expression in both cell lines (P < 0.05).
  • Upregulation of p53 and downregulation of bcl-2 observed in A549/CDDP cells post-transfection (P < 0.05).
  • Significant reduction in the resistance index of A549/CDDP cells from 21.52 to 4.14 after GRP75 silencing.

Conclusions:

  • Cisplatin resistance in lung cancer is linked to GRP75 gene overexpression.
  • GRP75 plays a regulatory role in the expression of p53 and bcl-2.
  • Targeting GRP75 may represent a viable strategy to overcome cisplatin resistance in lung cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K